paclitaxel has been researched along with Erythroderma, Sezary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bates, SE; Fojo, T; Kayastha, GL; Piekarz, RL; Robey, RW; Zhan, Z | 1 |
1 trial(s) available for paclitaxel and Erythroderma, Sezary
Article | Year |
---|---|
Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176).
Topics: Acetylation; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Renal Cell; Colonic Neoplasms; Depsipeptides; Didanosine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Hippocalcin; Histones; Humans; Kidney; Kidney Neoplasms; Leukocytes, Mononuclear; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neoplastic Cells, Circulating; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sezary Syndrome; Tumor Cells, Cultured | 2006 |